Literature DB >> 2519975

Study of the lipoprotein pattern among workers exposed to lead.

R M el-Gazzar, S A el-Hefny, K H Noweir, M Y Shamy.   

Abstract

Occupational exposure to lead fumes constitutes a serious problem in Egypt, since a considerable number of workers might be involved in its deleterious effect. The present study aimed to elucidate the effect of lead exposure on the lipoprotein pattern of exposed workers. The study has been carried out in a plant manufacturing lead batteries. It consists of 89 workers exposed to lead and 25 control subjects. Fasting blood samples were collected for the determination of serum lipoprotein pattern and their cholesterol and phospholipid content. Levels of lead in blood and delta amino levulinic acid in urine have been determined as biological indices of lead exposure. Lead exposure caused mainly a cumulative effect on the cholesterol and phospholipid content of lipoproteins since only workers exposed for more than 10 years showed significant changes. These changes might be referred to the effect of lead exposure on liver and/or on trace metal metabolism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2519975

Source DB:  PubMed          Journal:  J Egypt Public Health Assoc        ISSN: 0013-2446


  3 in total

1.  The association between occupational lead exposure and serum cholesterol and lipoprotein levels.

Authors:  E Kristal-Boneh; D Coller; P Froom; G Harari; J Ribak
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

2.  Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.

Authors:  Manal Kamal; Mona M Fathy; Eman Taher; Manal Hasan; May Tolba
Journal:  Ann Saudi Med       Date:  2011 Sep-Oct       Impact factor: 1.526

3.  Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes.

Authors:  Wan-Fen Li; Mei-Hung Pan; Meng-Chu Chung; Chi-Kung Ho; Hung-Yi Chuang
Journal:  Environ Health Perspect       Date:  2006-08       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.